Friday 6 November 2026
Export IQV’s income statement to Excel — free account
IQVIA Holdings Inc.
IQV Healthcare Diagnostics & Research
IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024.
- Revenue
- +8.00%
- EPS
- +10.2%
- Free cash flow
- −21.3%
- Total debt
- +7.42%
Quarter to September 2026, against a year earlier
264.53
0.74
+0.28%
Follow IQV
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
32.29 | 23.77 | 20.95 | 28.43 |
+8 more quarters Free account |
P/S ratio |
2.56 | 1.89 | 1.73 | 2.38 | |
P/FCF ratio |
21.30 | 14.21 | 13.11 | 18.23 | |
P/Operating CF |
53.67 | 57.52 | 46.47 | 52.72 | |
P/B ratio |
6.52 | 5.09 | 4.52 | 5.84 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
3.35 | 2.71 | 2.55 | 3.21 | |
EV/EBITDA |
16.74 | 13.51 | 12.52 | 15.63 | |
EV/Operating CF |
21.17 | 16.32 | 15.70 | 19.72 | |
EV/FCF |
27.86 | 20.37 | 19.37 | 24.61 | |
Quick Ratio |
0.74 | 0.62 | 0.66 | 0.67 | |
Current Ratio |
0.83 | 0.71 | 0.75 | 0.75 | |
Net Debt/EBITDA |
15.19 | 17.31 | 16.99 | 14.30 | |
Debt/Assets |
52.72% | 53.54% | 53.35% | 52.51% | |
Debt/Equity |
2.37 | 2.54 | 2.49 | 2.37 | |
Asset Turnover |
0.58 | 0.58 | 0.58 | 0.57 | |
Operating CF/Net income |
2.36 | 2.18 | 2.26 | 1.43 | |
Capex/Depreciation |
(0.48) | (0.66) | (0.43) | (0.54) | |
Interest Coverage |
2.82 | 2.57 | 2.68 | 3.25 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
12.85% | 13.14% | 12.09% | 10.72% | |
Intangible Assets out of Total Assets |
0.71 | 0.71 | 0.72 | 0.72 | |
Share Based Compensation of Revenue |
1.87% | 2.17% | 1.57% | 1.37% | |
Graham Net Nets |
(0.39) | (0.54) | (0.60) | (0.44) | |
Graham Number |
87.89 | 83.30 | 83.10 | 82.96 | |
Earnings Yield |
3.10% | 4.21% | 4.77% | 3.52% | |
Free Cash Flow Yield |
4.70% | 7.04% | 7.63% | 5.49% | |
Revenue per Share |
26.89 | 26.30 | 24.65 | 25.39 | |
Operating CF per Share |
5.01 | 3.36 | 3.67 | 4.28 | |
Capex per Share |
(0.96) | (1.19) | (0.75) | (1.01) | |
Free Cash Flow per Share |
4.05 | 2.17 | 2.92 | 3.26 | |
Cash per Share |
14.71 | 12.52 | 12.49 | 12.45 | |
Shareholders Equity per Share |
41.23 | 37.94 | 37.70 | 38.57 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
41.23 | 37.94 | 37.70 | 38.57 | |
Free Cash Flow |
667.00 | 360.00 | 491.00 | 561.00 | |
Working Capital |
(1,326.00) | (2,589.00) | (2,109.00) | (2,089.00) | |
Capital Expenditures |
(158.00) | (198.00) | (127.00) | (174.00) | |
Net Current Asset Value |
(17,232.00) | (17,354.00) | (17,106.00) | (17,065.00) | |
EV/EBIT |
26.10 | 20.91 | 19.30 | 23.98 | |
Capex to Sales |
0.04 | 0.05 | 0.03 | 0.04 | |
Price to Operating Income |
19.95 | 14.59 | 13.05 | 17.76 | |
| Other line items | |||||
Average Receivables |
3,323.00 | 3,396.50 | 3,343.00 | 3,333.50 | |
Average Payables |
3,613.00 | 3,503.50 | 3,599.00 | 3,717.50 | |
Average Assets |
29,600.50 | 29,256.50 | 28,498.50 | 28,421.50 | |
Average Common Equity |
6,539.50 | 6,043.50 | 6,167.00 | 6,348.50 |
Columns are period end dates · fundamentals updated 2 Nov 2026